The ABCs of systemic healthcare reform - Cerner Corporation

More documents

Recommendations

Info

Signatures Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CERNER CORPORATION Dated: March 2, 2009 By:/s/Neal L. Patterson Neal L. Patterson Chairman of the Board and Chief Executive Officer Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated: Signature and Title Date /s/Neal L. Patterson March 2, 2009 Neal L. Patterson, Chairman of the Board and Chief Executive Officer (Principal Executive Officer) /s/Clifford W. Illig March 2, 2009 Clifford W. Illig, Vice Chairman and Director /s/Marc G. Naughton March 2, 2009 Marc G. Naughton, Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) /s/Gerald E. Bisbee, Jr. March 2, 2009 Gerald E. Bisbee, Jr., Ph.D., Director /s/John C. Danforth March 2, 2009 John C. Danforth, Director /s/Nancy-Ann DeParle March 2, 2009 Nancy-Ann DeParle, Director /s/Michael E. Herman March 2, 2009 Michael E. Herman, Director /s/William B. Neaves March 2, 2009 William B. Neaves, Ph.D., Director /s/William D. Zollars March 2, 2009 William D. Zollars, Director 56
Report of Independent Registered Public Accounting Firm The Board of Directors and Stockholders Cerner Corporation: We have audited the internal control over financial reporting of Cerner Corporation as of January 3, 2009, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Cerner Corporation’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting, appearing in Item 9.A. Controls and Procedures. Our responsibility is to express an opinion on the Corporation’s internal control over financial reporting based on our audit. We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. In our opinion, Cerner Corporation maintained, in all material respects, effective internal control over financial reporting as of January 3, 2009, based on criteria established in Internal Control–Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Cerner Corporation and subsidiaries as of January 3, 2009 and December 29, 2007, and the related consolidated statements of operating earnings, changes in equity, and cash flows for each of the years in the three-year period ended January 3, 2009, and our report dated March 2, 2009 expressed an unqualified opinion on those consolidated financial statements. /s/KPMG LLP Kansas City, Missouri March 2, 2009 57
Page 1 and 2:
The ABCs of systemic healthcare ref
Page 3:
ANNUAL REPORT 2008 1
Page 6 and 7:
Board of Directors Neal L. Patterso
Page 8 and 9: To Cerner’s Shareholders, Clients
Page 10 and 11: As we have communicated, our long-t
Page 12 and 13: Key provisions of the ARRA designat
Page 14 and 15: most of our healthcare spending rel
Page 16 and 17: Appendix: Cerner’s Business Model
Page 18 and 19: that have allowed us to continue me
Page 20 and 21: A key point regarding our margin ex
Page 23 and 24: ANNUAL REPORT 2008 FORM 10-K 21
Page 25 and 26: PART I Item 1. Business Overview Ce
Page 27 and 28: total hours of effort needed to imp
Page 29 and 30: warranties concerning material erro
Page 31 and 32: known and unknown liabilities; 7) w
Page 33 and 34: Certain of our competitors have gre
Page 35 and 36: In July 2007, we entered into a lea
Page 37 and 38: Item 6. Selected Financial Data (1)
Page 39 and 40: Results Overview In a challenging e
Page 41 and 42: dispensing devices. Included in 200
Page 43 and 44: London which significantly enhances
Page 45 and 46: Net interest income was $1,269,000
Page 47 and 48: Liquidity and Capital Resources The
Page 49 and 50: The effects of inflation on the Com
Page 51 and 52: interest rates regularly reset ever
Page 53 and 54: PART III Item 10. Directors, Execut
Page 55 and 56: PART IV Item 15. Exhibits and Finan
Page 57: 10(r) 10(s) 10(t) 10(u) Cerner Corp
Page 65 and 66: (1) Summary of Significant Accounti
Page 67 and 68: Deferred revenue is comprised of de
Page 69 and 70: (n) Goodwill and Other Intangible A
Page 71 and 72: amounts that include the amounts at
Page 73 and 74: The Company performs ongoing credit
Page 75 and 76: The aggregate maturities for the Co
Page 77 and 78: Concurrently with the recognition o
Page 79 and 80: exercise and associate departure be
Page 81 and 82: own directly or indirectly, or hold
Page 83 and 84: The effective income tax rates for
Page 85 and 86: Accounting policies for each of the
Page 87 and 88: Stock Price Performance The followi
Page 92: World Headquarters Cerner Worldwide
show all

The ABCs of systemic healthcare reform - Cerner Corporation

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?